StonvexLoading…
StonvexStonvexStonvexCore line items from SGRY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $810.90M | $3.31B | $2.42B | $1.60B |
Operating Income | $65.80M | $389.50M | $279.30M | $173.60M |
Net Income | $-35.90M | $-77.90M | $-62.90M | $-40.20M |
EPS (Diluted) | $-0.28 | $-0.61 | $-0.50 | $-0.32 |
Total Assets | $8.04B | $8.12B | $7.95B | $7.95B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $182.30M | $239.90M | $203.40M | $250.10M |
Free Cash Flow OCF − CapEx | $-4.30M | $195.60M | $105.00M | $41.20M |
Shares Outstanding | 130.80M | 129.32M | 129.02M | 128.21M |